Preferred Label : golimumab;
MeSH note : Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally
well tolerated in patients with an inadequate response to MTX.;
CISMeF synonym : simponi;
MeSH hyponym : CNTO 148;
Is substance : O;
UNII : 91X1KLU43E;
Origin ID : C529000;
UMLS CUI : C2353893;
ATC code(s)
Exact mapping(s) to DCI
- golimumab [International Nonproprietary Name]
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
- golimumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3539141/fr/simponi-golimumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
biological therapy
golimumab
injections, subcutaneous
---
https://ansm.sante.fr/informations-de-securite/simponi-golimumab-50-mg-et-100-mg-modifications-importantes-des-instructions-dutilisation-du-stylo-prerempli-smartject
2023
false
false
false
France
French
guidelines for drug use
golimumab
pharmacovigilance note
Pre-filled Pen Syringe
injections, subcutaneous
Device malfunction
---
https://www.has-sante.fr/jcms/p_3295747/fr/simponi-golimumab
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
golimumab
injections, subcutaneous
golimumab
arthritis, rheumatoid
arthritis, psoriatic
spondylitis, ankylosing
evaluation of the transparency committee
---
https://www.ansm.sante.fr/actualites/modification-des-conditions-de-prescription-et-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques-en-rhumatologie-gastroenterologie-dermatologie-ophtalmologie
2019
false
false
false
France
French
drug prescriptions
drug information
Adalimumab
Etanercept
golimumab
Certolizumab Pegol
anakinra
interleukin 1 receptor antagonist protein
antibodies, monoclonal
---
https://www.has-sante.fr/jcms/p_3096551/fr/simponi
2019
false
false
false
France
golimumab
drug therapy, combination
methotrexate
child
arthritis, juvenile
injections, subcutaneous
evaluation of the transparency committee
golimumab
antibodies, monoclonal
---
https://www.has-sante.fr/portail/jcms/c_2893489/fr/simponi
https://www.has-sante.fr/portail/jcms/c_2893489/fr/simponi-golimumab-anti-tnf
2018
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
golimumab
golimumab
injections, subcutaneous
child
Polyarticular juvenile idiopathic arthritis
arthritis, juvenile
guidelines for drug use
tumor necrosis factor-alpha
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors
---
https://www.revmed.ch/RMS/2017/RMS-N-553/Effets-secondaires-des-traitements-biologiques
2017
false
false
false
Switzerland
French
journal article
biological therapy
Inflammatory joint disease
Infliximab
antirheumatic agents
gastrointestinal agents
Etanercept
Adalimumab
Certolizumab Pegol
golimumab
Drug-Related side effects and adverse reactions
Infection reactivation
Reinfection tuberculosis (disorder)
Reactivation of hepatitis B viral hepatitis (disorder)
Reactivation of hepatitis C viral hepatitis (disorder)
leukoencephalopathy, progressive multifocal
lymphoproliferative disorders
cardiovascular diseases
Liver function tests outside reference range (finding)
hypercholesterolemia
leukopenia
hypogammaglobulinemia
antibodies, antinuclear
Injection related reaction
Injection site reaction
drug eruptions
Drug-induced pneumonitis (disorder)
tumor necrosis factors
opportunistic infections
agammaglobulinemia
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors
---
http://www.has-sante.fr/portail/jcms/c_2637481/fr/simponi
2016
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
golimumab
golimumab
golimumab
injections, subcutaneous
adult
Non-radiographic axial spondyloarthritis
spondylarthritis
antibodies, monoclonal
antibodies, monoclonal
---
Summary Safety Review - Tumour Necrosis Factor (TNF) alpha blockers (SIMPONI and CIMZIA)
- Assessing the Potential Risk of Liver Inflammation (Autoimmune Hepatitis)
https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tnf-fnt-2-fra.php
2016
false
false
false
Canada
French
tumor necrosis factor-alpha
drug evaluation
risk assessment
hepatitis, autoimmune
canada
Tumor necrosis factor alpha (TNF-α) inhibitors
psoriasis
arthritis, rheumatoid
crohn disease
colitis, ulcerative
golimumab
Certolizumab Pegol
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors
---
http://www.lecrat.eu/?s=Golimumab
2015
false
false
false
France
French
drug information
golimumab
golimumab
antibodies, monoclonal
---
http://www.has-sante.fr/portail/jcms/c_1728495/fr/simponi-golimumab-anti-tnf
2014
France
French
golimumab
golimumab
golimumab
injections, subcutaneous
tumor necrosis factor-alpha
colitis, ulcerative
guidelines for drug use
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
clinical trials as topic
corticosteroid therapy
antibodies, monoclonal
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors
---
http://www.meddispar.fr/SIMPONI-100-B-1/(type)/letter/(value)/S/(cip)/3400927568480
2014
false
true
false
France
French
drug information
golimumab
drug prescriptions
legislation, drug
injections, subcutaneous
golimumab
antibodies, monoclonal
---
http://www.meddispar.fr/Medicaments/SIMPONI-100-B-1/(type)/letter/(value)/S/(cip)/3400927568312
2014
false
true
false
France
French
drug information
golimumab
golimumab
drug prescriptions
legislation, drug
injections, subcutaneous
antibodies, monoclonal
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/simponi_01022012_avis_ct11419.pdf
http://www.has-sante.fr/portail/jcms/c_1218114/simponi
2012
France
French
evaluation of the transparency committee
golimumab
golimumab
antibodies, monoclonal
injections, subcutaneous
insurance, health, reimbursement
arthritis, rheumatoid
drug therapy, combination
arthritis, psoriatic
adult
spondylitis, ankylosing
treatment outcome
clinical trials, phase iii as topic
randomized controlled trials as topic
golimumab
antibodies, monoclonal
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/simponi_01022012_synthse_ct11419.pdf
http://www.has-sante.fr/portail/jcms/c_1218486/simponi-01022012-avis-ct11419
http://www.has-sante.fr/portail/jcms/c_1244042/simponi-golimumab-anti-tnf
2012
France
French
evaluation of the transparency committee
guidelines for drug use
arthritis, rheumatoid
arthritis, psoriatic
tumor necrosis factor-alpha
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
spondylitis, ankylosing
adult
golimumab
drug therapy, combination
methotrexate
aged
clinical trials, phase iii as topic
antibodies, monoclonal
golimumab
golimumab
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors
---
http://www.meddispar.fr/SIMPONI-50-B-1/(type)/letter/(value)/S/(cip)/3400939730974
2012
France
French
drug information
golimumab
golimumab
antibodies, monoclonal
drug prescriptions
legislation, drug
injections, subcutaneous
arthritis, psoriatic
spondylitis, ankylosing
arthritis, rheumatoid
---
http://www.meddispar.fr/Medicaments/SIMPONI-50-B-1/(type)/letter/(value)/S/(cip)/3400939730745
2012
France
French
drug information
drug prescriptions
legislation, drug
injections, subcutaneous
golimumab
golimumab
arthritis, rheumatoid
arthritis, psoriatic
spondylitis, ankylosing
antibodies, monoclonal
---
https://www.ema.europa.eu/medicines/human/EPAR/Simponi
2012
United Kingdom
English
French
syndication feed
antibodies, monoclonal
antibodies, monoclonal
golimumab
golimumab
drug approval
drug labeling
treatment outcome
injections, subcutaneous
arthritis, rheumatoid
arthritis, psoriatic
spondylitis, ankylosing
tumor necrosis factor-alpha
adult
aged
drug interactions
pregnancy
breast feeding
drug therapy, combination
golimumab
antibodies, monoclonal
package leaflet
summary of product characteristics
drug evaluation
Tumor Necrosis Factor Inhibitors
---
http://www.cochrane.org/fr/CD008341
2010
United Kingdom
France
French
meta-analysis
arthritis, rheumatoid
treatment outcome
antibodies, monoclonal
golimumab
french abstract
---